Food-inspired innovations to improve the stability of active pharmaceutical ingredients.


Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
25 Jul 2022
Historique:
received: 14 03 2022
revised: 23 05 2022
accepted: 26 05 2022
pubmed: 10 6 2022
medline: 14 7 2022
entrez: 9 6 2022
Statut: ppublish

Résumé

Food-processing and pharmaceutical industries share a lot of stability issues against the same physical, chemical, and microbiological phenomena. They also share some solutions to improve the stability as the use of preservatives and packaging. Ecological concerns lead to the development of tremendous innovations in food. Some of these innovations could also be beneficial in the pharmaceutical domain. The objective of this review is to evaluate the potential application of these findings in the pharmaceutical field and the main limits in terms of toxicity, environmental, economic and regulatory issues. The principal factors influencing the shelf-life were highlighted through the description of the stability studies usually performed in the pharmaceutical industry (according to European guidelines). To counter those factors, different solutions are currently available as preservatives and specific packaging. They were described and debated with an overview of recent food innovations in each field. The limits of the current solutions in the pharmaceutical field and the innovation in the food field have inspired a critical pharmaceutical outlook. The active and intelligent packaging for active pharmaceutical ingredients of the future is imagined.

Identifiants

pubmed: 35680111
pii: S0378-5173(22)00436-7
doi: 10.1016/j.ijpharm.2022.121881
pii:
doi:

Substances chimiques

Preservatives, Pharmaceutical 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

121881

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Célia Boukoufi (C)

Université de Lorraine, CITHEFOR, F-54000 Nancy, France; Pharmacy Department, University Hospital, 54511 Vandoeuvre-lès-Nancy, France.

Ariane Boudier (A)

Université de Lorraine, CITHEFOR, F-54000 Nancy, France.

Philippe Maincent (P)

Université de Lorraine, CITHEFOR, F-54000 Nancy, France.

Jean Vigneron (J)

Pharmacy Department, University Hospital, 54511 Vandoeuvre-lès-Nancy, France.

Igor Clarot (I)

Université de Lorraine, CITHEFOR, F-54000 Nancy, France. Electronic address: igor.clarot@univ-lorraine.fr.

Articles similaires

Using Bayh-Dole Act March-In Rights to Lower US Drug Prices.

Lisa Larrimore Ouellette, Bhaven N Sampat
1.00
United States Cross-Sectional Studies Patents as Topic Humans Drugs, Generic
Conflict of Interest Japan Humans Drug Industry Retrospective Studies
1.00
Humans Mastication Visual Cortex Male Female
Anaerobiosis Methane Sewage Microbiota RNA, Ribosomal, 16S

Classifications MeSH